Priming to Launch “Oligos as a Service”

In the final feature on Molecular Assemblies, Big4Bio spoke with Stephen Bates, vice president of sales and marketing, about the year ahead for the company as it prepares to commercialize its synthetic DNAs. Companies to Watch – Molecular Assemblies by Marie Daghlian Stephen Bates has come full circle in a long career in sales and […]

Read More

Podcast: The Write Stuff — Reinventing the Synthesis of DNA With Enzymes

Companies to Watch – Molecular Assemblies The Big4Bio Podcast · The Write Stuff: Reinventing the Synthesis of DNA with Enzymes Molecular Assemblies’ President and CEO Mike Kamdar and Co-Founder and Chief Scientific Officer Bill Efcavitch talk more about the company’s enzymatic synthesis of DNA and its plans for commercialization.   NEXT WEEK: Q&A with Molecular […]

Read More

Moving Synthetic Biology Into the 21st Century

In the second of four features on Molecular Assemblies, based on a conversation with CEO and President Mike Kamdar and Co-founder and Chief Scientific Officer Bill Efcavitch, Big4Bio takes a deeper look at the company’s enzymatic DNA synthesis technology, why it is needed, and the markets it serves. Companies to Watch – Molecular Assemblies by […]

Read More

Changing the Paradigm for Writing DNA

In the first of four features on Molecular Assemblies, Big4Bio spoke with CEO and President Mike Kamdar and Co-founder and Chief Scientific Officer Bill Efcavitch about how the company got started, their technology for synthesizing DNA and why it is better than current methods, and their plans moving forward. The second feature will provide an […]

Read More

The Big4Bio Company to Watch Program
September 2021: Molecular Assemblies

THE COMPANY/THE MISSION Changing the Paradigm for Writing DNA Molecular Assemblies’ leaders detail how the company got started, the company’s technology for synthesizing DNA, and why that technology is better than current methods.     THE TECHNOLOGY, PART 1 Moving Synthetic Biology into the 21st Century A deeper look at the company’s enzymatic DNA synthesis […]

Read More